Duopharma’s new RM578mil contracts a positive

TA Research said it maintained its APPL sales contribution forecast for Duopharma at RM198mil for 2024.

PETALING JAYA: Duopharma Biotech Bhd’s shares gained 6.8% yesterday on news that the company has secured contracts worth RM578.1mil for the supply of pharmaceutical and/or non-pharmaceutical products.

Closing at RM1.26, the counter was up eight sen, off an intra-day high of RM1.29.

Duopharma on Tuesday announced that it had accepted 11 letters of offer from Pharmaniaga Logistics Sdn Bhd for the supply of 86 pharmaceutical and/or non-pharmaceutical products worth RM578.1mil to offices and facilities operated and controlled by the government.

The pharmaceutical company said all the contracts would remain valid and binding until Dec 31, 2026 or such other date as directed by the government.

TA Research said while the contracts would be positive for Duopharma, the win was not a surprise development, noting the company’s management had earlier shared that price negotiations for the new approved products purchase list (APPL) contract were concluded in February 2024.

“We believe that the 86 stock keeping unit (SKUs) won (versus 50 SKUs previously) will bode well for the group,” the brokerage explained in a research note yesterday.

The research house said it maintained its APPL sales contribution forecast for Duopharma at RM198mil for 2024 and RM217mil for both 2025 and 2026, even after incorporating the latest contracts.

TA Research maintained its “buy” call on Duopharma, with an unchanged target price of RM1.47, pegged to a price-earnings multiple of 16 times estimated FY25 earnings.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

US producer prices unexpectedly fall in May
Apollo’s net profit jumps 70% to RM53.8mil in FY24
Sunview secures large scale solar project from Uzbekistan
Ringgit further strengthens versus US dollar at the close
Leon Fuat shareholders approve final dividend payout
FTSE4Good Bursa Malaysia Index sees 12 new inclusions
Solarvest buys office and retail space for RM48.73mil
Malaysia keeps inflation outlook for 2024 after diesel subsidy reforms
BNM to revamp its fund for SMEs deployment
Cabnet Holdings unit bags RM46mil sub-contract works

Others Also Read